Improvement of brain tissue oxygenation during cerebrovascular insufficiency by interfering with the catecholaminergic system.
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001810:Blood Volume; D001921:Brain / Q000378:metabolism*; D001971:Bromocriptine / Q000494:pharmacology; D002415:Cats; D002561:Cerebrovascular Disorders / Q000097:blood*; D004873:Ergolines / Q000494:pharmacology; D010100:Oxygen / Q000097:blood*; D010643:Phenoxybenzamine / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D010643:Phenoxybenzamine; D001971:Bromocriptine; D001058:Apomorphine; D010100:Oxygen